| 标题 |
74636 Results from an Open-Label Phase 2 Trial of ATI-2138, an investigational oral covalent inhibitor of interleukin-2-inducible T cell kinase (ITK) and Janus kinase 3 (JAK3), in patients with moderate-to-severe atopic dermatitis |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of the American Academy of Dermatology 作者:Ajay Aggarwal; Aparna Kaul; Loreen Stillwell; Nancy McGraw; Robert Maher; et al 出版日期:2026-07-06 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)